BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6432936)

  • 1. An evaluation of four different luminescence immunoassay systems: CELIA (chemiluminescent immunoassay), SPALT (solid-phase antigen luminescence technique), ILMA (immunoluminometric assay) and ILSA (immunoluminometric labelled second antibody). A critical study of macro solid phases for use in immunoassay systems, Part III.
    Wood WG; Fricke H; Haritz J; Gadow A; Krausz HS; Tode B; Strasburger CJ; Scriba PC
    J Clin Chem Clin Biochem; 1984 May; 22(5):349-56. PubMed ID: 6432936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of luminescent tracers and hapten-protein conjugates for use in luminescence immunoassays with immobilised antibodies and antigens. A critical study of macro solid phases for use in immunoassay systems, Part II.
    Gadow A; Fricke H; Strasburger CJ; Wood WG
    J Clin Chem Clin Biochem; 1984 May; 22(5):337-47. PubMed ID: 6470624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of serum thyroxine by solid-phase chemiluminescence immunoassay.
    Weerasekera DA; Kim JB; Barnard GJ; Collins WP
    Ann Clin Biochem; 1983 Mar; 20 Pt 2():100-4. PubMed ID: 6847114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ceruloplasmin in the diagnosis of gynecologic tumors].
    Schultek T; Tode B; Wood WG
    J Clin Chem Clin Biochem; 1986 Mar; 24(3):179-84. PubMed ID: 3711801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of an immunoradiometric and an immunoluminometric assay for the evaluation of the tumour associated antigens CA 19-9 and CA 125.
    Mader RM; Steger GG; Braun J; Rainer H
    Eur J Clin Chem Clin Biochem; 1994 Feb; 32(2):85-90. PubMed ID: 8003582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a sensitive immunoluminometric assay for the determination of C-reactive protein (CRP) in serum and plasma and the establishment of reference ranges for different groups of subjects.
    Wood WG; Lüdemann J; Mitusch R; Heinrich J; Maass R; Frick U
    Clin Lab; 2000; 46(3-4):131-40. PubMed ID: 10791120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of commercially available luminescence enhanced enzyme immunoassays with in-house non-radioisotopic assays for thyroxine binding globulin and total thyroxine.
    Wood WG; Rohde C; Jacobs A
    J Clin Chem Clin Biochem; 1988 Mar; 26(3):135-40. PubMed ID: 3133446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid phase antigen luminescent immunoassays (SPALT) for the determination of insulin, insulin antibodies and gentamicin levels in human serum.
    Wood WG; Fricke H; von Klitzing L; Strasburger CJ; Scriba PC
    J Clin Chem Clin Biochem; 1982 Nov; 20(11):825-31. PubMed ID: 6759609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The measurement of serum cortisol by a solid-phase chemiluminescence immunoassay.
    Lindström L; Meurling L; Lövgren T
    J Steroid Biochem; 1982 Apr; 16(4):577-80. PubMed ID: 7087482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunoassay for plasma cortisol based on chemiluminescence.
    Kohen F; Pazzagli M; Kim JB; Lindner HR
    Steroids; 1980 Oct; 36(4):421-37. PubMed ID: 7444993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of nonradioactive chemiluminescent immunoassay methods for the analysis of thyroxine and cortisol in blood samples obtained from dogs, cats, and horses.
    Singh AK; Jiang Y; White T; Spassova D
    J Vet Diagn Invest; 1997 Jul; 9(3):261-8. PubMed ID: 9249165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoluminometric assay of chromogranin A in serum with commercially available reagents.
    Bender H; Maier A; Wiedenmann B; O'Connor DT; Messner K; Schmidt-Gayk H
    Clin Chem; 1992 Nov; 38(11):2267-72. PubMed ID: 1424122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A luminescent label for the immunoassay of oxytocin.
    Lequin RM; Moss RJ; van Nispen JW
    J Immunoassay; 1986; 7(3):169-79. PubMed ID: 3745445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CA 19-9 and CA 125 determination by immunoluminometric assay.
    Plebani M; Faggian D; Masiero M; Giacomini A; Burlina A
    J Clin Chem Clin Biochem; 1990 Dec; 28(12):919-21. PubMed ID: 2081962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemiluminescent labelled streptavidin (STAV) as a universal marker in steroid and peptide immunoassays.
    Strasburger CJ; Kohen F
    J Biolumin Chemilumin; 1989 Jul; 4(1):112-8. PubMed ID: 2801206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luminescence immunoassay (LIA): a solid-phase immunoassay monitored by chemiluminescence.
    Olsson T; Brunius G; Carlsson HE; Thore A
    J Immunol Methods; 1979; 25(2):127-35. PubMed ID: 370310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new luminescence immunoassay for thyrotropin using coated tubes: evaluation and comparison with immunoradiometric assay.
    Pilo A; Zucchelli GC; Ferdeghini M; Masini S; Calvo S
    J Biolumin Chemilumin; 1989 Jul; 4(1):185-90. PubMed ID: 2801211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new immunoluminometric solid phase sandwich assay for antibodies to hepatitis B surface antigen].
    Missler U; Wood WG
    J Clin Chem Clin Biochem; 1988 Sep; 26(9):569-72. PubMed ID: 3199079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assay for urinary estriol-16 alpha-glucuronide based on antibody-enhanced chemiluminescence.
    Kohen F; Kim JB; Barnard G; Lindner HR
    Steroids; 1980 Oct; 36(4):405-19. PubMed ID: 7444992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoassay labels based on chemiluminescence and bioluminescence.
    Seitz WR
    Clin Biochem; 1984 Apr; 17(2):120-5. PubMed ID: 6375893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.